{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T18:20:23Z","timestamp":1779906023216,"version":"3.53.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,2,15]],"date-time":"2011-02-15T00:00:00Z","timestamp":1297728000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cell Biochem Biophys"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1007\/s12013-011-9156-x","type":"journal-article","created":{"date-parts":[[2011,2,14]],"date-time":"2011-02-14T06:35:05Z","timestamp":1297665305000},"page":"23-31","source":"Crossref","is-referenced-by-count":17,"title":["Aspirin Attenuates Pulmonary Arterial Hypertension in Rats by Reducing Plasma 5-Hydroxytryptamine Levels"],"prefix":"10.1007","volume":"61","author":[{"given":"Lan","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieyan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,2,15]]},"reference":[{"issue":"1","key":"9156_CR1","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ccm.2006.11.010","volume":"28","author":"RM Tuder","year":"2007","unstructured":"Tuder, R. M., Marecki, J. C., Richter, A., et al. (2007). Pathology of pulmonary hypertension. Clinics in Chest Medicine, 28(1), 23\u201342, vii.","journal-title":"Clinics in Chest Medicine"},{"issue":"1","key":"9156_CR2","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/MAJ.0b013e3181c078d7","volume":"339","author":"C Carlino","year":"2010","unstructured":"Carlino, C., Tobias, J. D., Schneider, R. I., et al. (2010). Pulmonary hemodynamic response to acute combination and monotherapy with sildenafil and brain natriuretic peptide in rats with monocrotaline-induced pulmonary hypertension. American Journal of the Medical Sciences, 339(1), 55\u201359.","journal-title":"American Journal of the Medical Sciences"},{"issue":"2\u20133","key":"9156_CR3","first-page":"160","volume":"27","author":"HP Gurtner","year":"1985","unstructured":"Gurtner, H. P. (1985). Aminorex and pulmonary hypertension. A review. Cor et Vasa, 27(2\u20133), 160\u2013171.","journal-title":"Cor et Vasa"},{"issue":"2","key":"9156_CR4","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/sj.bjp.0703570","volume":"131","author":"MR MacLean","year":"2000","unstructured":"MacLean, M. R., Herve, P., Eddahibi, S., et al. (2000). 5-hydroxytryptamine and the pulmonary circulation: Receptors, transporters and relevance to pulmonary arterial hypertension. British Journal of Pharmacology, 131(2), 161\u2013168.","journal-title":"British Journal of Pharmacology"},{"key":"9156_CR5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1742-1241.2007.01497.x","volume":"156","author":"MR MacLean","year":"2007","unstructured":"MacLean, M. R. (2007). Pulmonary hypertension and the serotonin hypothesis: Where are we now? International Journal of Clinical Practice Supplement, 156, 27\u201331.","journal-title":"International Journal of Clinical Practice Supplement"},{"issue":"9","key":"9156_CR6","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1093\/cvr\/27.9.1619","volume":"27","author":"Y Kanai","year":"1993","unstructured":"Kanai, Y., Hori, S., Tanaka, T., et al. (1993). Role of 5-hydroxytryptamine in the progression of monocrotaline induced pulmonary hypertension in rats. Cardiovascular Research, 27(9), 1619\u20131623.","journal-title":"Cardiovascular Research"},{"issue":"3","key":"9156_CR7","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0002-9343(99)80156-9","volume":"99","author":"P Herve","year":"1995","unstructured":"Herve, P., Launay, J. M., Scrobohaci, M. L., et al. (1995). Increased plasma serotonin in primary pulmonary hypertension. American Journal of Medicine, 99(3), 249\u2013254.","journal-title":"American Journal of Medicine"},{"issue":"21","key":"9156_CR8","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1161\/CIRCULATIONAHA.104.524926","volume":"111","author":"C Guignabert","year":"2005","unstructured":"Guignabert, C., Raffestin, B., Benferhat, R., et al. (2005). Serotonin transporter inhibition prevents and reverses monocrotaline-induced pulmonary hypertension in rats. Circulation, 111(21), 2812\u20132819.","journal-title":"Circulation"},{"issue":"3","key":"9156_CR9","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.cardiores.2003.09.023","volume":"60","author":"E Hironaka","year":"2003","unstructured":"Hironaka, E., Hongo, M., Sakai, A., et al. (2003). Serotonin receptor antagonist inhibits monocrotaline-induced pulmonary hypertension and prolongs survival in rats. Cardiovascular Research, 60(3), 692\u2013699.","journal-title":"Cardiovascular Research"},{"issue":"2","key":"9156_CR10","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/0378-4347(95)00119-4","volume":"669","author":"TH Tsai","year":"1995","unstructured":"Tsai, T. H., Tsai, W. J., & Chen, C. F. (1995). Aspirin inhibits collagen-induced platelet serotonin release, as measured by microbore high-performance liquid chromatography with electrochemical detection. Journal of Chromatography. B Biomedical Applications, 669(2), 404\u2013407.","journal-title":"Journal of Chromatography. B Biomedical Applications"},{"issue":"Suppl 3","key":"9156_CR11","first-page":"40","volume":"8","author":"CF De","year":"1990","unstructured":"De, C. F. (1990). The role of serotonin in thrombogenesis. Clinical Physiology and Biochemistry, 8(Suppl 3), 40\u201349.","journal-title":"Clinical Physiology and Biochemistry"},{"issue":"4","key":"9156_CR12","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1159\/000194026","volume":"37","author":"D Kentera","year":"1979","unstructured":"Kentera, D., Susic, D., & Zdravkovic, M. (1979). Effects of verapamil and aspirin on experimental chronic hypoxic pulmonary hypertension and right ventricular hypertrophy in rats. Respiration, 37(4), 192\u2013196.","journal-title":"Respiration"},{"issue":"4 Pt 1","key":"9156_CR13","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1164\/ajrccm\/145.4_Pt_1.806","volume":"145","author":"M Delcroix","year":"1992","unstructured":"Delcroix, M., Melot, C., Lejeune, P., et al. (1992). Cyclooxygenase inhibition aggravates pulmonary hypertension and deteriorates gas exchange in canine pulmonary embolism. American Review of Respiratory Disease, 145(4 Pt 1), 806\u2013810.","journal-title":"American Review of Respiratory Disease"},{"issue":"4","key":"9156_CR14","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1080\/10937409809524557","volume":"1","author":"AE Schultze","year":"1998","unstructured":"Schultze, A. E., & Roth, R. A. (1998). Chronic pulmonary hypertension\u2014the monocrotaline model and involvement of the hemostatic system. Journal of Toxicology and Environmental Health Part B: Critical Reviews, 1(4), 271\u2013346.","journal-title":"Journal of Toxicology and Environmental Health Part B: Critical Reviews"},{"issue":"8","key":"9156_CR15","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1172\/JCI200112805","volume":"108","author":"S Eddahibi","year":"2001","unstructured":"Eddahibi, S., Humbert, M., Fadel, E., et al. (2001). Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension. Journal of Clinical Investigation, 108(8), 1141\u20131150.","journal-title":"Journal of Clinical Investigation"},{"issue":"10","key":"9156_CR16","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1161\/01.RES.0000222546.45372.a0","volume":"98","author":"C Guignabert","year":"2006","unstructured":"Guignabert, C., Izikki, M., Tu, L. I., et al. (2006). Transgenic mice overexpressing the 5-hydroxytryptamine transporter gene in smooth muscle develop pulmonary hypertension. Circulation Research, 98(10), 1323\u20131330.","journal-title":"Circulation Research"},{"issue":"3","key":"9156_CR17","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/cvr\/cvp306","volume":"85","author":"I Morecroft","year":"2010","unstructured":"Morecroft, I., Pang, L., Baranowska, M., et al. (2010). In vivo effects of a combined 5-HT1B receptor\/SERT antagonist in experimental pulmonary hypertension. Cardiovascular Research, 85(3), 593\u2013603.","journal-title":"Cardiovascular Research"},{"issue":"24","key":"9156_CR18","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1161\/01.CIR.0000132476.87231.6F","volume":"109","author":"JH Newman","year":"2004","unstructured":"Newman, J. H., Fanburg, B. L., Archer, S. L., et al. (2004). Pulmonary arterial hypertension: Future directions: Report of a National Heart, Lung and Blood Institute\/Office of Rare Diseases workshop. Circulation, 109(24), 2947\u20132952.","journal-title":"Circulation"},{"key":"9156_CR19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1471-2466-8-25","volume":"8","author":"R Dumitrascu","year":"2008","unstructured":"Dumitrascu, R., Koebrich, S., Dony, E., et al. (2008). Characterization of a murine model of monocrotaline pyrrole-induced acute lung injury. BMC Pulmonary Medicine, 8, 25.","journal-title":"BMC Pulmonary Medicine"},{"issue":"2","key":"9156_CR20","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1177\/0192623307311402","volume":"36","author":"MF Ramos","year":"2008","unstructured":"Ramos, M. F., Lame, M. W., Segall, H. J., et al. (2008). Smad signaling in the rat model of monocrotaline pulmonary hypertension. Toxicologic Pathology, 36(2), 311\u2013320.","journal-title":"Toxicologic Pathology"},{"issue":"5\u20136","key":"9156_CR21","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0049-3848(03)00379-7","volume":"110","author":"JR Vane","year":"2003","unstructured":"Vane, J. R., & Botting, R. M. (2003). The mechanism of action of aspirin. Thrombosis Research, 110(5\u20136), 255\u2013258.","journal-title":"Thrombosis Research"},{"issue":"2","key":"9156_CR22","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1378\/chest.130.2.545","volume":"130","author":"SR Johnson","year":"2006","unstructured":"Johnson, S. R., Granton, J. T., & Mehta, S. (2006). Thrombotic arteriopathy and anticoagulation in pulmonary hypertension. Chest, 130(2), 545\u2013552.","journal-title":"Chest"},{"issue":"2","key":"9156_CR23","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1378\/chest.128.2.714","volume":"128","author":"J Shen","year":"2005","unstructured":"Shen, J., He, B., & Wang, B. (2005). Effects of lipo-prostaglandin E1 on pulmonary hemodynamics and clinical outcomes in patients with pulmonary arterial hypertension. Chest, 128(2), 714\u2013719.","journal-title":"Chest"},{"issue":"3","key":"9156_CR24","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1183\/09031936.06.00095705","volume":"27","author":"IM Robbins","year":"2006","unstructured":"Robbins, I. M., Kawut, S. M., Yung, D., et al. (2006). A study of aspirin and clopidogrel in idiopathic pulmonary arterial hypertension. European Respiratory Journal, 27(3), 578\u2013584.","journal-title":"European Respiratory Journal"}],"container-title":["Cell Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-011-9156-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12013-011-9156-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-011-9156-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T01:39:49Z","timestamp":1559439589000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12013-011-9156-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,15]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["9156"],"URL":"https:\/\/doi.org\/10.1007\/s12013-011-9156-x","relation":{},"ISSN":["1085-9195","1559-0283"],"issn-type":[{"value":"1085-9195","type":"print"},{"value":"1559-0283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,15]]}}}